Bioalternatives is a contract research organization (CRO) specializing in cellular and molecular pharmacology.
Our laboratory is committed to developing effective in vitro alternative options to animal experimentation methods, by offering a full range of solutions for preclinical research and for the development of drug candidates or of active ingredients and cosmetic formulations.
FibroTx brings personalized treatment closer to the customer in areas of clinical dermatology and skin care. FibroTx easy to use skin molecular diagnostic tests allow unparalleled possibilities for non-invasive skin biomarker research and product development in clinical dermatology and skin care.
Genemarkers helps personal care, nutrition & pharma companies create effective products using genomics. Primary services include genotyping, gene expression & microRNA analysis. Our off-the-shelf gene expression panels are an easy, affordable way to add genomic screening to your product development.
As a Clinical Research Organization specialized in Dermatology, we provide scientific guidance, accurate results and customer satisfaction. Our unique service offering combines specialized Contract Research Services, knowledge of dermatology sites in North America and the extended capabilities of a large clinical research site.
ImaBiotech supports pharmaceutical industry with innovative Imaging services that predict more accurately which treatment will work in stratified population ImaBiotech is a Contract Research Organization (CRO) with two facilities one in Boston (MA) and one in France. The company offers innovative services to the pharmaceutical research to provide better drug efficacy and toxicity evaluations from preclinical to clinical stages, making better and safer drugs. Services are based on different imaging techniques combined to Quantitative Mass Spectrometry a technology developed and constantly improved by ImaBiotech. Quantitative Mass Spectrometry (QMSI) has been developed for decades and allows to detect elements and molecules without labelling. ImaBiotech has developed the quantitative aspects through many patents making ImaBiotech the worldwide leader in this field. QMSI is a game changer of the pharmaceutical industry in all therapeutic areas. While actual techniques provide global information, this molecular technique brings deeper information about drug localization and its pharmacology effects to recover disease tissues and damaged cells. This increases the interpretation of drug efficacy and toxicity improving drugs and improving time to market. To interpret datas we’ve developed, thanks to our patents, two softwares called Quantinetix and Multimaging to interpret pharmacology in tissue.
Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Our medicines & pipeline are designed to help patients with eye disease, heart disease, allergic & inflammatory diseases, pain, cancer, infectious diseases & rare diseases. Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions. Since 2007, Sanofi & Regeneron have collaborated to develop & commercialize fully human monoclonal antibodies utilizing proprietary technologies.
Zen-Bio is a leading global provider of advanced cell-based solutions and services to the life science, cosmetics, and personal care communities. The company, founded in 1995, was a pioneer in adipose derived stem cells (ASCs) and continues this legacy by providing cutting edge human primary cell culture products and services. Our mission is to provide the highest quality human cell systems, reagents, blood products and contract services to our research partners; to develop and commercialize innovative research tools, leverage our expertise through research and development and strategic alliances that accelerate discovery.
Genoskin Inc. is a biotechnology company based in Boston (MA) and Toulouse (France) that provides unique standardized and ready-to-use ex vivo human skin models to predict efficacy and toxicity of chemical, pharmaceutical and cosmetic products, as well as medical devices, as an alternative to animal experiments. Our cutting-edge technology enables the evaluation of topical and systemic administration, subcutaneous injection and anti-Th1/Th17 inflammatory drugs. We also provide tools for tissue culture as well as in-house R&D services. The company is ISO9001:2015 certified.
MatTek Corporation, an in vitro life sciences company, is at the forefront of tissue engineering and is a leader in the production of 3D reconstructed human tissue models. As efficient and cost-effective replacements to traditional animal models, products like EpiDermFT and MelanoDerm provide cosmetics chemists and formulators with an ethical and accurate means of assessing safety and efficacy of cosmetics ingredients and final formulations.
Lipotype is a leading lipidomics provider and delivers comprehensive, absolutely quantitative lipid analysis services for clinical and biological samples on a high-throughput scale. Drawing on many years of cutting edge research experience, Lipotype offers high quality lipid analysis services for a wide range of customers and applications including biomarker identification for clinical researchers, pharma and biotech companies, functional food development for the food industry, claim support for the cosmetics industry, as well as for the small-scale profiling needs of academic researchers. Lipotype is a spin-off company from the Kai Simons and Andrej Shevchenko labs of the world-renowned Max-Planck-Institute of Molecular Cell Biology and Genetics in Dresden, Germany.